In contrast to its protective effect, several human and animal studies have demonstrated that IL-6 is elevated in alcoholic liver disease, NAFLD, NASH, and cirrhosis [9], [11], [28], [29]. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.